Etodolac
| Status | Commercial |
| Development phase | |
| Therapeutic cat. | Musculo-skeletal |
| Polymorphic form | Crystalline racemate, none |
| CAS No. | 41340-25-4 |
| Reference Product | |
| Injectable Form | |
| EU DMF readiness |  |
| CEP | |
| CHINESE DMF | |
| JAPANESE DMF | |
| KOREAN DMF | |
| CANADIAN DMF | |
| CADIFA | |
| US DMF readiness | |
| OEB No. | |
| Samples |
Drug description
Etodolac is a nonsteroidal anti-inflammatory drug (NSAID). It works by reducing hormones that cause inflammation and pain in the body. Etodolac is used to treat mild to moderate pain, osteoarthritis, or rheumatoid arthritis. Etodolac may also be used for purposes not listed in this medication guide.
Polpharma API
- Long experience in in-house commercial manufacturing
- Wide regulatory documentation
Disclaimer
Products protected by patents (SPC) in Poland are developed solely for the purpose of Regulatory Submissions or R&D purposes intended to support Regulatory Submissions. These products are not offered for sale or made available in countries where such products are subject to patent (SPC) protection and where the offer for sale or any related activity constitutes patent infringement. It is within the buyer’s responsibility and liability to check the patent situation of the product in the import market(s).
